The Department of Health and Social Care has published the latest Voluntary Scheme sales data for Q4 2019 which brings the total branded growth rate for 2019 versus 2018 to 1.6%.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to this outbreak.
The Chancellor Rishi Sunak has delivered his first Budget, and the first for the Government following last year's General Election.
The Department for International Trade has published the UK's approach to free trade negotiations with the US.
Our President Haseeb Ahmad sets out how industry is working to find treatments and cures for some of the world’s most complex diseases. Nowhere is the need to find new medicines more acute than in rare diseases, many of which are genetic and affect the youngest patients.
The UK Government has set out its approach to negotiations for the Future Relationship with the EU.
We spoke to Dr Lucy McKay, CEO of the charity Medics4RareDiseases. She told us why health professionals should ‘dare to think rare’ in their patients.
Prabhjot is a is a university lecturer in living in London. She describes her experience of living with polymyositis.
Karen Owen lives with a condition called hereditary angioedema (HAE). She has learned to take control of HAE through self-management techniques and peer support.
February is Raynaud’s awareness month. Physiotherapist and Parkinson’s dance teacher Liz Hooks has the condition and for her, a little kindness and the offer of some hot water would go a long way to help manage it.